The Regence Group Medical Policy Manual Table of Contents

Search:

» Medical Policy

» Medication Policy

» Dental Policy

» Behavioral Health Policy

» Clinical Position Statements

» ConsumerTx

Browse alphabetically for topics addressed in TRG Medical Policies:
A	B	C	D	E
F	G	H	I	J
K	L	M	N	O
P	Q	R	S	T
U	V	W	X	Y
Z

Index

Please note: We are continually adding items to improve this index. If you are unable to find the term you are looking for, may we suggest you use the search engine at the top of this page to conduct a search for the term.

Last updated: (March 10, 2010)

Facet arthroplasty

Facet joint injections, back pain

Facet replacement

Facet solutions

Fallopian tube cancer; allogeneic

Fallopian tube cancer; autologous

Familion

FAMM

Fanconi's anemia; allogeneic

FAST

Fecal incontinence, biofeedback

Femoral artery wall thickness study to screen for coronary artery disease, ultrasound

Femoroacetabular Impingement

Fetal surgery

Fiberoptic analysis, colon polyps

Fibroids, ultrasound ablation

FirstCyte Breast Test (Cytc); assess breast cancer risk

FlexiCore artificial disc

Fluorescent allergosorbent test (FAST)

Focused microwave phase array thermotherapy

Focused ultrasound, brain

Focused ultrasound, breast

Fugo blade, glaucoma

Fulcrum assisted soft stabilization (FASS)

Functional neuromuscular stimulation

Funnel chest repair

Comments from physicians and other health care practitioners regarding TRG medical policies are welcome. If you are a physician and have a question or comment regarding a medical policy, please contact the medical policy staff through our secure form.


	The Blue Cross and/or Blue Shield Plans comprising The Regence Group serve Idaho, Oregon, Utah and much of Washington state. The Regence Group and each of its affiliate Plans are independent licensees of the Blue Cross and Blue Shield Association.